Newsfeeds - Spark Newswire

1 minute read

Amarin Announced New REDUCE-IT Data Showing Benefit Of VASCEPA/VAZKEPA In High-Risk Patients With A Recent Acute Coronary Syndrome Event

Today, 5:52 AM

Amarin Corporation plc (NASDAQ: AMRN) today announced a new analysis from the VASCEPA/VAZKEPA (icosapent ethyl) cardiovascular outcomes REDUCE-IT study showing the effectiveness of VASCEPA®/VAZKEPA® in patients with recent acute coronary syndrome (<12 months before randomization).

AMRN

11 minute read

Earnings

Earnings Scheduled For March 1, 2023

By Benzinga Insights

Today, 5:52 AM

Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million.

AAN

1 minute read

Amarin Corporation Shareholders Have Voted To Elect All 7 Of Sarissa’s Nominees, Remove Per Wold-Olsen As Chairman Of Board Effective Immediately

By Happy Mohamed

Today, 5:52 AM

Amarin Corporation plc (NASDAQ:AMRN) ("Amarin" or the "Company") today announced that, based on the preliminary voting results provided by its proxy solicitors following the Company's 2023 General Meeting of Shareholders (the "General Meeting"), Amarin shareholders have voted to elect all sev

AMRN

4 minute read

Amarin Urges Shareholders To Vote “Against” Sarissa’s Harmful Proposals At Upcoming General Meeting Says ‘It Has No Plan, No New Ideas And An Underqualified Slate’

By Happy Mohamed

Today, 5:52 AM

The NEW Amarin and NEW Board is On the Right Track – Leading Independent Experts, ISS and Glass Lewis, Agree that Sarissa Representation is Not Warranted Sarissa's Misguided Campaign to Remove

AMRN

1 minute read

Uncategorized

Amarin Shareholder Sarissa Urge Shareholders To Vote “For” Sarissa Nominees And “For” Removal Of Chairman Per Wold-Olsen

By Benzinga Newsdesk

Today, 5:52 AM

Sarissa urge all shareholders to vote "FOR" the Sarissa Nominees and "FOR" the removal of Chairman Per Wold-Olsen on or prior to the deadline on Tuesday, February 21, 2023.

AMRN

4 minute read

Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

Today, 5:52 AM

Gainers

ACCD

2 minute read

Sarissa Capital Submits Notice To Call A Special Meeting Of Amarin Shareholders To Add Directors And Remove Chairman Per Wold Olsen

By Benzinga Newsdesk

Today, 5:52 AM

Sarissa believes current board lacks any remaining credibility for representing shareholders Sarissa is astonished that Amarin board refuses to add shareholder representatives

AMRN

20 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For January 6, 2023

By Benzinga Insights

Today, 5:52 AM

Upgrades Piper Sandler upgraded the previous rating for Aligos Therapeutics Inc (NASDAQ:ALGS) from Neutral to Overweight. Aligos Therapeutics…

AGTI

1 minute read

Jefferies Upgrades Amarin Corp to Buy, Raises Price Target to $3

By Benzinga Newsdesk

Today, 5:52 AM

Jefferies analyst Michael Yee upgrades Amarin Corp (NASDAQ:AMRN) from Hold to Buy and raises the price target from $1.3 to $3.

AMRN

2 minute read

Amarin Announces VAZKEPA Receives Regulatory Approval In Switzerland

By Benzinga Newsdesk

Today, 5:52 AM

-- Amarin Continuing Process for Obtaining National Pricing and Reimbursement in Switzerland in the Course of 2023 -- -- Swissmedic Approval Underpins Company's Presence and Expansion in Switzerland as its

AMRN